2024 Annual Meeting | C33 - Behavioral Neurology

Date Sunday 04/14/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Location Colorado Convention Center | Four Seasons 1

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Roy H. Hamilton, MD, MS, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should be able to recognize recent research advances in the use of noninvasive neuromodulation techniques to study and treat aphasia, comprehend the important role of the cerebellum in the modulation and control of cognition, and identify the ways in which discoveries in visual neuroscience translate to advances in the clinical care of persons with neurodegenerative disorders

CME Available 2.00 CME credits

Core Competencies Medical Knowledge

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:30 AM MDT	Speaker	Neuromodulation in the Treatment of Aphasia Roy H. Hamilton, MD, MS, FAAN
07:30 AM - 07:40 AM MDT	Q&A	Questions & Answers Roy H. Hamilton, MD, MS, FAAN
07:40 AM - 08:10 AM MDT	Speaker	The Cognitive Cerebellum Chi-Ying (Roy) Lin, MD, FAAN
08:10 AM - 08:20 AM MDT	Q&A	Questions and Answers Chi-Ying (Roy) Lin, MD, FAAN
08:20 AM - 08:50 AM MDT	Speaker	Vision, Cognition, and Neurodegeneration Victoria S. Pelak, MD, FAAN
08:50 AM - 09:00 AM MDT	Q&A	Questions & Answers Victoria S. Pelak, MD, FAAN

Faculty Disclosures
Roy H. Hamilton, MD, MS, FAAN	Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology (Journal). The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Victoria S. Pelak, MD, FAAN	Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.